- Home
- COLD vs RNA Comparison
COLD vs RNA Comparison
Compare COLD & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLD
- RNA
- Stock Information
- Founded
- COLD 1903
- RNA 2012
- Country
- COLD United States
- RNA United States
- Employees
- COLD N/A
- RNA N/A
- Industry
- COLD Real Estate Investment Trusts
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- COLD Real Estate
- RNA Health Care
- Exchange
- COLD Nasdaq
- RNA Nasdaq
- Market Cap
- COLD 3.9B
- RNA 4.0B
- IPO Year
- COLD 2018
- RNA 2020
- Fundamental
- Price
- COLD $11.75
- RNA $69.82
- Analyst Decision
- COLD Hold
- RNA Buy
- Analyst Count
- COLD 15
- RNA 20
- Target Price
- COLD $18.40
- RNA $69.26
- AVG Volume (30 Days)
- COLD 5.9M
- RNA 9.8M
- Earning Date
- COLD 11-06-2025
- RNA 11-07-2025
- Dividend Yield
- COLD 7.83%
- RNA N/A
- EPS Growth
- COLD N/A
- RNA N/A
- EPS
- COLD N/A
- RNA N/A
- Revenue
- COLD $2,607,407,000.00
- RNA $10,729,000.00
- Revenue This Year
- COLD N/A
- RNA N/A
- Revenue Next Year
- COLD $2.11
- RNA $108.97
- P/E Ratio
- COLD N/A
- RNA N/A
- Revenue Growth
- COLD N/A
- RNA 1.23
- 52 Week Low
- COLD $11.46
- RNA $21.51
- 52 Week High
- COLD $24.74
- RNA $70.51
- Technical
- Relative Strength Index (RSI)
- COLD 31.82
- RNA 79.30
- Support Level
- COLD $12.35
- RNA $69.50
- Resistance Level
- COLD $12.80
- RNA $69.86
- Average True Range (ATR)
- COLD 0.51
- RNA 0.88
- MACD
- COLD -0.16
- RNA 0.81
- Stochastic Oscillator
- COLD 9.97
- RNA 91.19
About COLD Americold Realty Trust Inc.
Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 239 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.